TrialArteriosclerosis, thrombosis, and vascular biology2010

Pioglitazone versus glimepiride on coronary artery calcium progression in patients with type 2 diabetes mellitus: a secondary end point of the CHICAGO study.

Michael H Davidson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.